Component: (Network and Table)
Network
00100 - Statement - Condensed Consolidated Balance Sheets
(http://www.blueprintmedicines.com/role/StatementCondensedConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001597264 (http://www.sec.gov/CIK)
Statement of Financial Position [Abstract]Period [Axis]
2016-12-31
2015-12-31
Statement of Financial Position [Abstract]
 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
52,069,000  
162,707,000  
Investments, available-for-sale
162,090,000  
 
Restricted cash
 
119,000  
Unbilled accounts receivable
3,577,000  
3,414,000  
Prepaid expenses and other current assets
2,689,000  
4,176,000  
Total current assets
220,425,000  
 
170,416,000  
 
Investments, available-for-sale
54,059,000  
 
Property and equipment, net
6,188,000  
6,661,000  
Other assets
856,000  
555,000  
Restricted cash
1,267,000  
1,266,000  
Total assets
282,795,000  
 
178,898,000  
 
Liabilities and stockholders' equity
 
 
Current liabilities:
 
 
Accounts payable
2,211,000  
2,455,000  
Accrued expenses
11,746,000  
6,443,000  
Current portion of deferred revenue
11,426,000  
5,898,000  
Current portion of lease incentive obligation
578,000  
578,000  
Current portion of term loan payable
2,551,000  
3,266,000  
Total current liabilities
28,512,000  
 
18,640,000  
 
Deferred rent, net of current portion
932,000  
842,000  
Deferred revenue, net of current portion
35,809,000  
7,742,000  
Lease incentive obligation, net of current portion
2,792,000  
3,370,000  
Term loan payable, net of current portion
1,518,000  
4,072,000  
Other long term liabilities
154,000  
253,000  
Commitments (Note 11)
xsi:nil  
xsi:nil  
Stockholders' deficit:
 
 
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding
xsi:nil  
xsi:nil  
Common stock, $0.001 par value; 120,000,000 shares authorized; 33,125,479 and 27,196,053 shares issued at December 31, 2016 and December 31, 2015, respectively, and 33,123,354 and 27,065,558 shares outstanding at December 31, 2016 and December 31, 2015, respectively
33,000  
27,000  
Additional paid-in capital
420,533,000  
278,927,000  
Accumulated other comprehensive income
(18,000) 
 
Accumulated deficit
(207,470,000) 
(134,975,000) 
Total stockholders' equity
213,078,000  
 
143,979,000  
 
Total liabilities and stockholders' equity
282,795,000  
 
178,898,000